Oxaliplatin resistance in pancreatic ductal adenocarcinoma is non‑significantly mediated by diminished drug uptake but is highly linked to a poor apoptotic response to the cytotoxic threat
Oncology Reports · 2025
DOI: 10.3892/or.2025.9027 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Reports, 2025. Verfasst von Hellen Röttgen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine IX‑Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University, Medical Faculty Heidelberg, Heidelberg Univ…. Hauptthemen laut MEDLINE: Oxaliplatin, Drug Resistance, Neoplasm, Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Internal Medicine IX‑Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University, Medical Faculty Heidelberg, Heidelberg University Hospital, D‑69120 Heidelberg, Germany.
- Department of Food Chemistry and Toxicology, Karlsruhe Institute of Technology, D‑76131 Karlsruhe, Germany.
- Department of General, Visceral, and Transplantation Surgery, Heidelberg University, Medical Faculty Heidelberg, Heidelberg University Hospital, D‑69120 Heidelberg, Germany.
Zitieren
APA
Röttgen, H., Theurer, L., Peccerella, T., Sandu, K., Weiss, J., Burhenne, J., Neoptolemos, J. P., Köberle, B., & Theile, D. (2025). Oxaliplatin resistance in pancreatic ductal adenocarcinoma is non‑significantly mediated by diminished drug uptake but is highly linked to a poor apoptotic response to the cytotoxic threat. Oncology Reports. https://doi.org/10.3892/or.2025.9027
Vancouver
Röttgen H, Theurer L, Peccerella T, Sandu K, Weiss J, Burhenne J, et al. Oxaliplatin resistance in pancreatic ductal adenocarcinoma is non‑significantly mediated by diminished drug uptake but is highly linked to a poor apoptotic response to the cytotoxic threat. Oncology Reports. 2025. doi:10.3892/or.2025.9027
BibTeX
@article{Rttgen2025,
author = {Röttgen, Hellen and Theurer, Lana and Peccerella, Teresa and Sandu, Ketaki and Weiss, Johanna and Burhenne, Jürgen and Neoptolemos, John P and Köberle, Beate and Theile, Dirk},
title = {Oxaliplatin resistance in pancreatic ductal adenocarcinoma is non‑significantly mediated by diminished drug uptake but is highly linked to a poor apoptotic response to the cytotoxic threat},
journal = {Oncology Reports},
year = {2025},
doi = {10.3892/or.2025.9027}
}
EUVIMED